Related Experiment Video
Updated: Jan 17, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Lotus seed starch-chlorogenic acid complexes alleviated chronic colitis and linked cognitive dysfunction via gut
Xiaoying Wang1, Shiqi Wang1, Baodong Zheng1
1College of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China; Fujian Provincial Key Laboratory of Quality Science and Processing Technology in Special Starch, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Abstract:
This study aims to reveal the protective mechanism of lotus seed starch-chlorogenic acid complexes (A-LS-CA) at different doses on chronic colitis and cognitive dysfunction induced by Dextran sulfate sodium. Here, A-LS-CA alleviated the pathological symptoms of mice chronic colitis in a dose-dependent manner, including improving the disease activity index, the colon length and tissue damage. It was remarkable that 2 g/kg A-LS-CA reduced the mRNA expressions and protein levels of TNF-α, IL-6, IL-1β, NF-κB and TLR4 of the colon tissue in DSS-induced chronic colitis mice. In addition, 2 g/kg A-LS-CA enhanced the level of ZO-1 and Claudin-1, which were 1.75 and 1.63 folds higher than that of the model group, respectively. In particular, A-LS-CA reshaped the gut microbiota of mice with chronic colitis and promoted the production of key metabolites, including short-chain fatty acids and tryptamine. Therefore, we speculated that A-LS-CA has a positive effect on gut microbiota and its metabolites, thereby alleviating behavioral disorders of mice with chronic colitis. In conclusion, these findings provide a research basis for starch-polyphenol complex to improve chronic colitis and cognitive dysfunction via gut-brain-axis balance.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome III: Medical and Nursing Management

